Margaret Schwarz

  • 2800 Citations
  • 25 h-Index
1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Margaret Schwarz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Lung Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Bronchopulmonary Dysplasia Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Vascular Endothelial Growth Factor A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1998 2016

Blood Vessels
Bronchopulmonary Dysplasia
Lung
Vascular Endothelial Growth Factor Receptor
Ubiquitin
Morphogenesis
Lung
Blood Vessels
Fetal Development
Transgenic Mice
Lung
Blood Vessels
Angiogenesis Inducing Agents
Fetal Development
Growth and Development
Lung
Cell Proliferation
Blood Vessels
Cell Cycle
Angiogenesis Inducing Agents

Publications 1992 2019

  • 2800 Citations
  • 25 h-Index
  • 74 Article
  • 1 Chapter

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer

Awasthi, N., Kronenberger, D., Stefaniak, A., Hassan, M. S., von Holzen, U., Schwarz, M. & Schwarz, R. E., Sep 10 2019, In : Cancer Letters. 459, p. 41-49 9 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Phosphatidylinositol 3-Kinases
Drug Therapy
Adenocarcinoma
1 Citation (Scopus)

Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer

Awasthi, N., Mikels-Vigdal, A. J., Stefanutti, E., Schwarz, M., Monahan, S., Smith, V. & Schwarz, R. E., Jun 1 2019, In : Journal of Cellular and Molecular Medicine. 23, 6, p. 3878-3887 10 p.

Research output: Contribution to journalArticle

Open Access
Matrix Metalloproteinase 9
Pancreatic Neoplasms
Drug Therapy
Antibodies
Therapeutics
1 Citation (Scopus)

Augmentation of Nab-Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models

Awasthi, N., Schwarz, M., Zhang, C. & Schwarz, R. E., Nov 1 2018, In : Molecular Cancer Therapeutics. 17, 11, p. 2353-2364 12 p.

Research output: Contribution to journalArticle

Angiogenesis Inhibitors
Stomach Neoplasms
Adenocarcinoma
Stomach
Drug Therapy
4 Citations (Scopus)

Inhibition of the MEK/ERK pathway augments nab-paclitaxelbased chemotherapy effects in preclinical models of pancreatic cancer

Awasthi, N., Monahan, S., Stefaniak, A., Schwarz, M. & Schwarz, R. E., Jan 1 2018, In : Oncotarget. 9, 4, p. 5274-5286 13 p.

Research output: Contribution to journalArticle

MAP Kinase Signaling System
Pancreatic Neoplasms
gemcitabine
Drug Therapy
Adenocarcinoma